Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations-Reference-Cited by-同舟云学术

Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations

Published:2018-07-27 Issue:4 Volume:4 Page:237-242
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Hallén Jonas¹,Sreeharan Nadarajah²

Affiliation:

1. Novartis Norge AS, Nydalen Alle 37, Oslo, Norway

2. Institute of Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London, UK

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/4/4/237/25719616/pvy029.pdf

Reference44 articles.

1. Heart disease and stroke statistics—2015 update;Mozzafarian;Circulation,2015

2. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association;Miller;Circulation,2011

3. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries;Kotseva;Eur J Cardiovasc Prev Rehabil,2009

4. Hypertriglyceridemia and its pharmacologic treatment among us adults;Ford;Arch Internal Med,2009

5. Obesity and dyslipidemia in South Asians;Misra;Nutrients,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders;Pharmacological Research;2023-08

2. Efficacy and Safety of Da-Chai-Hu-Tang in Lipid Profiles in High-Risk, Statin-Treated Patients with Residual HyperTG: A 12-Week, Randomized, Active-Control, Open Clinical Study;Life;2022-03-11

3. Cardiac and Metabolic Impact of Functional Foods with Antioxidant Properties Based on Whey Derived Proteins Enriched with Hemp Seed Oil;Antioxidants;2020-10-30

4. Effects of Xuezhitong in Patients with Hypertriglyceridemia: a Multicentre, Randomized, Double-Blind, Double Simulation, Positive Drug and Placebo Parallel Control Study;Cardiovascular Drugs and Therapy;2020-03-23

5. Monitoring of biomarkers in heart failure;European Heart Journal Supplements;2019-12-01